Facts
The French Swimming Federation (Fédération Française de Natation, FFN) charges respondent M57 for a violation of the Anti-Doping Rules. During a water polo match on January 16, 2010, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisone, prednisolone and a metabolite of cannabis. These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list and are regarded as a specified substancea.

History
The respondent used medication to treat a pain in his shoulder, he has a medical certificate for this. The cause for the positive test for a metabolite for cannabis is passive smoking during parties from friends who use this prohibited substance. The proof for the shoulder injury and treatment is valid, but the amount of the metabolites of cannabis is inconsistent with passive smoking.

Decision
1. The sanction is a period of ineligibility of six months, in which respondent can't take part in competition or manifestation organized or authorized by the FFN.
2. The period of ineligibility will be reduced by the period already served by the decision (3 months period of ineligibility), dated April 9, 2010, by the disciplinary committee of the FFN.
3. The decision, dated April 9, 2010, by the disciplinary committee of the FFN should be modified.
4. The decision start on the date of notification.
5. The decision will be published and sent to the parties involved.

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M56 for a violation of the Anti-Doping Rules. During a cycling event on August 27, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence heptaminol. Heptaminol is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The Respondent didn't provide any information about how the prohibited substances had entered his body.

Decision
1. The sanction is a period of ineligibility of one year in which the respondent can't take part of competition or manifestations organized or authorized by the FFC, as pronounced by the decision dated March 3, 2010, by the disciplinary committee of the FFC, but extended to all relevant French sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

Facts
The French Boxing Federation (Fédération Française de Boxe, FFBoxe) - charges respondent M55 for a violation of the Anti-Doping Rules. During a match on December 19, 2009, a sample for a doping test purposes was taken. The sample tested positive on a metabolite of Cannabis. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list, it is regarded as a specified substance.

History
The respondent had used the prohibited substance in a private setting do deal with some personal problems she faced. There was no intention to enhance sport performance.

Decision
1. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or manifestations organized or authorized by the FFBoxe.
2.. The period of ineligibility should be reduced by the period already served by the decision (3 months period of ineligibility), dated March 30, 2010, by the disciplinary committee of the FFBoxe.
4. The decision, dated March 30, 2010, by the appeal committee of the FFBoxe should be modified.
5. The decision starts on the date of notification.
6. The decision will be published and sent to the parties involved.

Facts
The French Ski Federation (Fédération Française de Ski, FFS) charges respondent M54 with a violation of the Anti-Doping Rules. During a ski event on February 13, 2010, the respondent provided a sample for doping test purposes. His sample showed the presence of prednisolone and prednisone. Prednisolone and prednisone are prohibited substances on the World Anti-Doping Agency (WADA) prohibited list. They are regarded as specified substances.

History
The respondent used medication which contained the prohibited substances to treat a "sore throat" caused by the syndrome of Fernand Widal. However, the use of the medication was without prior consultation with a health professional. Furthermore, the medical documentation provided by the athlete on a long duration affection for an asthmatic condition from which he suffers, is not directly related to the symptoms which he says have suffered. The justification for therapeutic alleged by the latter can not be accepted.

Decision
1. The sanction is a one month period of ineligibility in which the respondent can't take part in competition or manifestations organized by the FFS.
2. The decision (a warning), dated May 21, 2010, of the disciplinary committee of the FFS should be modified.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Facts
The International Rugby Board (IRB) alleges Azat Abishev (the player) for a violation of the Anti-Doping Rules. The Player was tested as part of the Rugby World Cup 2011, a urine sample was taken from him on 17 July 2010. His sample tested positive for stanozolol and trenbolone. Stanozolol and trenbolone are Prohibited Substances listed as Anabolic Androgenic Steroid S1 in the World Anti-Doping Agency 2010 List of Prohibited Substances and Methods and in Schedule 2 to the Program.

History
The player admits the anti-doping rule violation now and accepts the
prescribed sanction.

Decision
The sanction for the anti-doping rule violation committed by the Player on 22 May 2010 by reason of the presence in the Player’s sample of stanozolol and trenbolone is a period of ineligibility of two (2) years.

Author: Ano Lobb
World J Gastroenterol. 2010 October 14; 16(38): 4880–4882.
Published online 2010 October 14. doi: 10.3748/wjg.v16.i38.4880

Weight loss supplements often contain powerful pharmacoactive ingredients with the potential to cause harm. Trials used to determine product safety and effectiveness, meanwhile, tend to be small, of short duration, and frequently lack financial conflict of interest disclosures. These factors could conspire to place consumers at risk, especially when published research cited in advertising cloaks products with the suggestion that their safety and effectiveness have been proven by science. Examples of current and former weight loss products backed by potentially conflicted or low quality research include Metabolife-356, Hydroxycut, Xenadrine and LeptiCore. Published research, especially in the field of weight loss supplements, needs better conflict of interest disclosure, and regulators should consider how research findings are used in marketing claims.

In September 2010 the Fédération Internationale de Volleyball (FIVB), the International Volleyball Federation, has reported an anti-doping rule violation against the minor Puertorican Athlete Ramon Burgos Mendez after his sample tested positive for the prohibited substance cannabis. After notification the Athlete filed a statement in his defence and was heard for the FIVB Disciplinary Panel.

The Athlete admitted the violation and stated that he smoked cannabis at a party 18 days before the doping test and expressed his regret.

The Panel concludes that the Athlete acted negligently without intention to enhance his sport performance.
Considering the principle of proportionality the FIVB Disciplinary Panel decides on 13 October 2010 to impose a 6 month period of ineligibility on the Athlete, starting on the date of the present decisions.

In September 2010 the Agenţia Naţională Anti-Doping (ANAD), the National Anti-Doping Agency of Romania, has reported an anti-doping rule violation against the Athlete Agoston Jozsef Moldovan after his sample tested positive for the prohibited substances stanozolol and clenbuterol.
At the hearing the Athlete admitted the use of the prohibited substances and did not request for the B sample analysis.
On 12 October 2010 the ANAD Hearing Commission decides to impose a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Anabolic-androgenic Steroids : A Possible New Risk Factor of Toxicant-Associated Fatty Liver Disease / Paulo Adriano Schwingel, Helma Pinchemel Cotrim, Bernardo Rios Salles, Carlos Eduardo Almeida, Crimério Ribeiro dos Santos Jr, Bruno Nachef, Antonio Ricardo Andrade, Cláudio Cesar Zoppi. - (Liver International 31 (2011) 3 (March); p. 348-353).

• PMID: 21040407.
• DOI: 10.1111/j.1478-3231.2010.02346.x

  Abstract

Background: Industrial toxin and drugs have been associated with non-alcoholic fatty liver disease (NAFLD); in these cases, the disease has been termed toxicant-associated steatohepatitis (TASH).

Aim: This study hypothesizes that the use of anabolic-androgenic steroids (AAS) could also be a risk factor to TASH or better toxicant-associated fatty liver disease (TAFLD) development.

Methodology: Case-control study including 180 non-competitive recreational male bodybuilders from August/2007 to March/2009. Ninety-five had a history of intramuscular AAS use (cases; G1) and 85 were non-users (controls; G2). They underwent a clinical evaluation and abdominal ultrasound, and their blood levels of aminotransferases, creatine phosphokinase (CPK), lipids, glucose and insulin were measured. TAFLD criteria: history of AAS use >2 years; presence of hepatic steatosis on ultrasound and/or aminotransferase alterations with normal CPK levels; exclusion of ethanol intake ≥20 g/day or use of other drugs; and exclusion of obesity, dyslipidaemia, diabetes and other liver diseases. Homeostasis model assessment for insulin resistance ≥3 was considered insulin resistant. Independent t-test, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated.

Results: All cases were asymptomatic. Clinical and laboratorial data were similar in G1 and G2 (P>0.05). TAFLD criteria were observed in 12.6% of the G1 cases and 2.4% of controls had criteria compliant with non-alcoholic fatty liver related to metabolic conditions. OR was 6.0 (95% CI: 1.3-27.6).

Conclusions: These results suggest that AAS could be a possible new risk factor for TAFLD. In this type of fatty liver disease, the individuals had a low body fat mass and they did not present insulin resistance.

Drug Free Sport New Zealand (DFSNZ) has reported an anti-doping rule violation against the Respondent after his sample tested positive for the prohibited substances Testosterone, Oxymesterone, Methandienone, Methyltestosterone, Oxymetholone, 19-norandrosterone. After notification a provisional suspension was ordered.

Respondent admitted the violation, did not submit a statement in his defence and waived his right to be heard before the Tribunal.
Therefore the Sports Tribunal of New Zealand decides to impose a 2 year period of ineligibility on the Respondent starting on the date of the provisional suspension.